This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deguchi, T.
Right arrow Articles by Kawada, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deguchi, T.
Right arrow Articles by Kawada, Y.

 Previous Article  |  Next Article 

Antimicrob. Agents Chemother., 11 1997, 2544-2546, Vol 41, No. 11
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Improved antimicrobial activity of DU-6859a, a new fluoroquinolone, against quinolone-resistant Klebsiella pneumoniae and Enterobacter cloacae isolates with alterations in GyrA and ParC proteins

T Deguchi, M Yasuda, , M Nakano, S Ozeki, E Kanematsu, Y Nishino and Y Kawada
Department of Urology, Gifu University School of Medicine, Japan.

MICs of DU-6859a, a novel fluoroquinolone, for 18 Klebsiella pneumoniae isolates and 21 Enterobacter cloacae isolates with altered GyrA or altered GyrA and ParC ranged from < or =0.025 to 6.25 microg/ml and from 0.1 to 3.13 microg/ml, respectively. Based on the MICs at which 90% of the isolates were inhibited for these strains of K. pneumoniae and E. cloacae, DU-6859a exhibited 16- to 256-fold-greater activity than currently available fluoroquinolones.


This article has been cited by other articles:

  • Lehtopolku, M., Hakanen, A. J., Siitonen, A., Huovinen, P., Kotilainen, P. (2005). In vitro activities of 11 fluoroquinolones against 226 Campylobacter jejuni strains isolated from Finnish patients, with special reference to ciprofloxacin resistance. J Antimicrob Chemother 56: 1134-1138 [Abstract] [Full Text]  
  • Martinez-Martinez, L., Pascual, A., Conejo, M. d. C., Garcia, I., Joyanes, P., Domenech-Sanchez, A., Benedi, V. J. (2002). Energy-Dependent Accumulation of Norfloxacin and Porin Expression in Clinical Isolates of Klebsiella pneumoniae and Relationship to Extended-Spectrum {beta}-Lactamase Production. Antimicrob. Agents Chemother. 46: 3926-3932 [Abstract] [Full Text]  
  • Kaneko, A., Sasaki, J., Shimadzu, M., Kanayama, A., Saika, T., Kobayashi, I. (2000). Comparison of gyrA and parC mutations and resistance levels among fluoroquinolone-resistant isolates and laboratory-derived mutants of oral streptococci. J Antimicrob Chemother 45: 771-775 [Abstract] [Full Text]  
  • Mouneimné, H., Robert, J., Jarlier, V., Cambau, E. (1999). Type II Topoisomerase Mutations in Ciprofloxacin-Resistant Strains of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43: 62-66 [Abstract] [Full Text]